Дапаглифлозин Полфарма

Дапаглифлозин Полфарма is an oral medication used to manage blood sugar levels in adults with type 2 diabetes. It belongs to the SGLT2 inhibitor class, helping reduce glucose reabsorption in the kidneys. This EU-manufactured product supports metabolic health as part of a broader treatment plan.

Дапаглифлозин Полфарма is prescribed to improve blood sugar control in adults with type 2 diabetes. It works by helping the kidneys remove excess glucose through urine, supporting overall metabolic balance. This medication is often used alongside diet and exercise to enhance its effects.

Users may notice improved blood sugar levels and potential weight loss as the body eliminates extra glucose. Some individuals report increased urination or thirst initially, which typically stabilizes over time. These effects reflect the medication’s mechanism of action in the body.

Store Дапаглифлозин Полфарма at room temperature, away from moisture and direct light. Keep it out of reach of children and pets. If you experience signs of dehydration or unusual symptoms, consult a healthcare provider promptly. Always follow the storage instructions provided with the medication.

Alcohol may increase the risk of dehydration or low blood sugar when combined with Дапаглифлозин Полфарма. Certain medications, such as diuretics or insulin, may interact with its effects. Discuss all current medications with a healthcare provider to avoid potential complications.